Sectors

KRYS
Krystal Biotech, Inc.
334.21
1 x 333.77
1 x 334.24
bid
ask
-
4.85
1.43%
10:03 AM
timesize
Ytd35.56%
1y120.02%
333.30
day range
341.67
130.50
52 week range
382.54
Open337.32Prev Close339.06Low333.30High341.67Mkt Cap10.00B
Vol19.76KAvg Vol334.60KEPS7.48P/E45.33Forward P/E44.84
Beta0.50Short Ratio9.04Inst. Own99.57%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0350-d Avg330.61200-d Avg265.381yr Est361.67

KRYS News

benzinga.com
Krystal Biotech Files Response With USPTO on KB801 Patent Application; Discontinues Clinical Study T

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001711279/000171127926000050/krys-20260721.htm

Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
prnewswire.com
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the

benzinga.com
Krystal Biotech To Replace Taylor Morrison Home In The S&P MidCap 400, And Tutor Perini To Replace K

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260720-1484359/1484359_tmhc-av

benzinga.com
B of A Securities Maintains Buy on Krystal Biotech, Raises Price Target to $396

B of A Securities analyst Alec Stranahan maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and r

benzinga.com
TD Cowen Maintains Buy on Krystal Biotech, Raises Price Target to $403

TD Cowen analyst Ritu Baral maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the pri

benzinga.com
HC Wainwright & Co. Maintains Buy on Krystal Biotech, Raises Price Target to $361

HC Wainwright & Co. analyst Joseph Pantginis maintains Krystal Biotech (NASDAQ:KRYS) with a B

benzinga.com
HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $310 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a

benzinga.com
HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $310 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a

benzinga.com
Krystal Biotech Says UK MHRA Grants Marketing Authorization To VYJUVEK For Treatment Of Wounds In Pa

VYJUVEK approved for the treatment of DEB from birth with flexible administration options similar to

benzinga.com
HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $310 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a

benzinga.com
MHRA Approves Beremagene Geperpavec For The Treatment Of Dystrophic Epidermolysis Bullosa

https://www.gov.uk/government/news/mhra-approves-beremagene-geperpavec-vyjuvek-for-the-treatment-of-

Krystal Biotech Analysts Boost Their Forecasts Following Upbeat Q1 Results
benzinga.com
Krystal Biotech Analysts Boost Their Forecasts Following Upbeat Q1 Results

Krystal Biotech (KRYS) reported strong Q1 earnings, beating analyst estimates and with potential for

benzinga.com
Citigroup Maintains Buy on Krystal Biotech, Raises Price Target to $378

Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises

benzinga.com
Evercore ISI Group Maintains Outperform on Krystal Biotech, Raises Price Target to $300

Evercore ISI Group analyst Gavin Clark-Gartner maintains Krystal Biotech (NASDAQ:KRYS) with a Out

benzinga.com
HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $310 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a

Krystal Biotech Q1 2026 Earnings Call Transcript
benzinga.com
Krystal Biotech Q1 2026 Earnings Call Transcript

Earnings Scheduled For May 4, 2026
benzinga.com
Earnings Scheduled For May 4, 2026

benzinga.com
Krystal Biotech Q1 EPS $1.83 Beats $1.39 Estimate, Sales $116.357M Beat $112.132M Estimate

Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $1.83 per share which beat the analyst

benzinga.com
Wolfe Research Initiates Coverage On Krystal Biotech with Peer Perform Rating

Wolfe Research analyst Kalpit Patel initiates coverage on Krystal Biotech (NASDAQ:KRYS) with a Pe

Earnings Scheduled For February 17, 2026
benzinga.com
Earnings Scheduled For February 17, 2026

Earnings Scheduled For November 3, 2025
benzinga.com
Earnings Scheduled For November 3, 2025

benzinga.com
Earnings Scheduled For August 4, 2025

benzinga.com
Earnings Scheduled For May 6, 2025

benzinga.com
Earnings Scheduled For February 19, 2025

benzinga.com
Earnings Scheduled For November 6, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023

benzinga.com
Stocks That Hit 52-Week Highs On Monday

  During Monday's morning session, 230 companies made new 52-week highs.

benzinga.com
Stocks that Broke 52-Week Highs Tuesday

Stocks that Broke 52-Week Highs Tuesday